Sage Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 24 2021 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical
company committed to developing novel therapies with the potential
to transform the lives of people with debilitating disorders of the
brain, announced today that the Company will participate in a
fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare
Conference on December 1 at 8:30am ET.
A live webcast of the fireside chat can be accessed on the
Investor page of Sage’s website at investor.sagerx.com. A replay of
the webcast will be available approximately two hours after the
completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to
developing novel therapies with the potential to transform the
lives of people with debilitating disorders of the brain. We are
pursuing new pathways with the goal of improving brain health, and
our depression, neurology and neuropsychiatry franchise programs
aim to change how brain disorders are thought about and treated.
Our mission is to make medicines that matter so people can get
better, sooner. For more information, please visit
www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211124005771/en/
Investor Helen Rubinstein 315-382-3979
Helen.Rubinstein@sagerx.com
Media Maureen L. Suda 617-949-4289
Maureen.Suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2023 to Sep 2024